view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Laura Dassama, PhD, assistant professor of microbiology and immunology and of chemistry, is developing new a new type of therapy for patients who, like her, live with sickle cell disease, which is caused by a mutation in the gene that codes for hemoglobin, the protein responsible for the ability of red blood cells to carry oxygen. Dassama speaks to her experience with the illness and describes how her lab work takes inspiration from a form of hemoglobin active during fetal development, creating a new path of inquiry that she hopes will yield a new treatment for the condition.
Read more in Stanford Medicine magazine:
https://stanmed.stanford.edu/innovations-help-chronically-ill-thrive/#sicklecell
Stanford Medicine Health Compass